|
|
 |
|
Viewing report
|
|
|
U.S. Emerging Cancer Therapeutics Markets
Frost & Sullivan, Jan 1999
This Frost & Sullivan report presents a thorough evaluation of the emerging cancer markets and their extensive product pipeline, giving your company an inside look at product development across the marketplace. Detailed product-based forecasting enables report users to follow the market's advance step by step. A technological assessment and market opportunity analysis is offered for the more nascent technologies, such as angiogenesis inhibitors. The report provides a comprehensive view of the market, identifying the competition, their lead product candidates, and key R&D and marketing strategies.
|
|
|
|
